Evidence map›Paper›PMID 39352656›Full record

ArticleBrazilian journal of microbiology : [publication of the Brazilian Society for Microbiology]2024

Prevalence and molecular characterization of carbapenem-resistant Enterobacterales in patients from a public referral hospital in a non-metropolitan region of Brazil during and post the SARS-CoV-2 pandemic.

Romário Costa Fochat, Ana Clara de Lelis Araújo, Olavo Dos Santos Pereira Júnior, Marcelo Silva Silvério, Alessandra Figueiredo de Castro Nassar, Maria de Lourdes Junqueira, Marcio Roberto Silva, Patrícia Guedes Garcia

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology], 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Romário Costa FochatPostgraduate Program in Collective Health, Federal University of Juiz de Fora, Juiz de Fora, Minas Gerais, Brazil.
Ana Clara de Lelis AraújoMolecular Biology Laboratory, College of Pharmacy, Federal University of Juiz de Fora, Juiz de Fora, Minas Gerais, Brazil.
Olavo Dos Santos Pereira JúniorMolecular Biology Laboratory, College of Pharmacy, Federal University of Juiz de Fora, Juiz de Fora, Minas Gerais, Brazil.
Marcelo Silva SilvérioMolecular Biology Laboratory, College of Pharmacy, Federal University of Juiz de Fora, Juiz de Fora, Minas Gerais, Brazil.
Alessandra Figueiredo de Castro NassarInstituto Biológico, Center for Research in Animal Health, São Paulo, São Paulo, Brazil.
Maria de Lourdes JunqueiraFederal University of Juiz de Fora, University Hospital, Juiz de Fora, Minas Gerais, Brazil.
Marcio Roberto SilvaPostgraduate Program in Collective Health, Federal University of Juiz de Fora, Juiz de Fora, Minas Gerais, Brazil.
Patrícia Guedes GarciaDepartment of Pharmaceutical Sciences, College of Pharmacy, Federal University of Juiz de Fora, Juiz de Fora, Minas Gerais, Brazil. patricia.guedes@ufjf.br.ORCID http://orcid.org/0000-0002-0795-6422

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Antimicrobial resistance (AMR) poses a global threat, with carbapenem-resistant Enterobacterales (CRE) representing a significant concern due to limited therapeutic options. This study investigated the prevalence of carbapenemase genes in CRE strains isolated from tracheal aspirates of patients at a Brazilian university hospital between January 2020 and August 2023. Bacterial identification was conducted using MALDI-TOF, while carbapenemase genes were detected by qPCR. Demographic and clinical data were collected, and univariate analysis was performed using the chi-square test (p < 0.05). Variables with p ≤ 0.10 were further investigated using the chi-square test for linear trend, along with stratified analysis. Out of 1,133 samples, 111 (9.79%) showed CRE growth, with 46 isolates included in the final sample, predominantly comprising Klebsiella pneumoniae (65.21%) and Serratia marcescens (19.57%). The bla

Indexed as

Carbapenem-Resistant EnterobacteriaceaeCOVID-19Enterobacteriaceae InfectionsAdolescentAdultAgedAged, 80 and overAnti-Bacterial AgentsBacterial Proteinsbeta-LactamasesBrazilCarbapenemsFemaleHospitals, PublicHumansKlebsiella pneumoniaeAnti-Bacterial AgentsBacterial Proteinsbeta-LactamasescarbapenemaseCarbapenemsAntimicrobial resistancebla KPCbla NDMKlebsiella pneumoniaeSerratia marcescensTracheal aspirate

Identifiers

PMID39352656
PMCPMC11711724

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.